-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Tonix Pharmaceuticals Holding Corp. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2016 to Q1 2024.
- Tonix Pharmaceuticals Holding Corp. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $1.21M, a 35.5% increase year-over-year.
- Tonix Pharmaceuticals Holding Corp. annual Depreciation, Depletion and Amortization for 2023 was $4.29M, a 242% increase from 2022.
- Tonix Pharmaceuticals Holding Corp. annual Depreciation, Depletion and Amortization for 2022 was $1.25M, a 2406% increase from 2021.
- Tonix Pharmaceuticals Holding Corp. annual Depreciation, Depletion and Amortization for 2021 was $50K, a 85.2% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)